Anaphylaxis epidemiology in patients with and patients without asthma: A United Kingdom database review

Journal of Allergy and Clinical Immunology

Volumn 125, Issue 5, 2010, Pages

  González Pérez, Antonio ^a,b   Aponte, Zuleika ^c   Vidaurre, Carlos Fernández ^d   Rodríguez, Luis Alberto García ^a  

^a Department of Pharmacoepidemiology   (Spain)

^b Edificio Acropolis Modulos 110 111   (Spain)

^c Departamento médico   (Spain)

^d NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN; ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; CYCLOOXYGENASE 2 INHIBITOR; HISTAMINE H2 RECEPTOR ANTAGONIST; MUSCARINIC RECEPTOR BLOCKING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PROTON PUMP INHIBITOR; STEROID; THEOPHYLLINE;

ADOLESCENT; ADULT; ALLERGIC RHINITIS; ANAPHYLACTIC SHOCK; ANAPHYLAXIS; ARTICLE; ASTHMA; ATOPIC DERMATITIS; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; FEMALE; FOOD ALLERGY; HUMAN; HYPERTENSION; INCIDENCE; INSECT STING; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; SENSITIVITY ANALYSIS; SEX DIFFERENCE; UNITED KINGDOM;

EID: 77951665382     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2010.02.009     Document Type: Article

References (23)

1. Sampson H.A., Munoz-Furlong A., Campbell R.L., Franklin Adkinson N., Bock S.A., Branum A., et al. Second symposium on the definition and management of anaphylaxis: summary report-Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network Symposium. J Allergy Clin Immunol 117 (2006) 391-397
2. Sampson H.A., Munoz-Furlong A., Bock S.A., Schmitt C., Bass R., Chowdhury B.A., et al. Symposium on the definition and management of anaphylaxis: summary report. J Allergy Clin Immunol 115 (2005) 584-591
3. Brown A.F.T., McKinnon D., and Chu K. Emergency department anaphylaxis: a review of 142 patients in a single year. J Allergy Clin Immunol 108 (2001) 861-866
4. Brown S.G.A. Clinical features and severity grading of anaphylaxis. J Allergy Clin Immunol 114 (2004) 371-376
5. Kemp S.F., Lockey R.F., Wolf B.L., and Lieberman P. Anaphylaxis: a review of 266 cases. Arch Intern Med 155 (1995) 1749-1754
6. Novembre E., Cianferoni A., Bernardini R., Mugnaini L., Caffarelli C., Cavagni G., et al. Anaphylaxis in children: clinical and allergologic features. Pediatrics 101 (1998) E8
7. Lewis J.D., Schinnar R., Bilker W.B., Wang X., and Strom B.L. Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf 16 (2007) 393-401
8. Suissa S., Ernst P., and Kezouh A. Regular use of inhaled corticosteroids and the long term prevention of hospitalisation for asthma. Thorax 57 (2002) 880-884
9. Bohlke K., Davis R.L., DeStefano F., Marcy S.M., Braun M.M., and Thompson R.S. Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organization. J Allergy Clin Immunol 113 (2004) 536-542
10. Klein J.S., and Yocum M.W. Underreporting of anaphylaxis in a community emergency room. J Allergy Clin Immunol 95 (1995) 637-638
11. van der Klauw M.M., Stricker B.H., Herings R.M., Cost W.S., Valkenburg H.A., and Wilson J.H.P. A population based case-cohort study of drug-induced anaphylaxis. Br J Clin Pharmacol 35 (1993) 400-408
12. Peng M.M., and Jick H. A population-based study of the incidence, cause, and severity of anaphylaxis in the United Kingdom. Arch Intern Med 164 (2004) 317-319
13. Sheikh A., Hippisley-Cox J., Newton J., and Fenty J. Trends in national incidence, lifetime prevalence and adrenaline prescribing for anaphylaxis in England. J R Soc Med 101 (2008) 139-143
14. Decker W.W., Campbell R.L., Manivannan V., Luke A., St. Sauver J.L., Weaver A., et al. The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester Epidemiology Project. J Allergy Clin Immunol 122 (2008) 1161-1165
15. Lieberman P., Camargo Jr. C.A., Bohlke K., Jick H., Miller R.L., Sheikh A., et al. Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma, and Immunology Epidemiology of Anaphylaxis Working Group. Ann Allergy Asthma Immunol 97 (2006) 596-602
16. Simons F.E., Peterson S., and Black C.D. Epinephrine dispensing patterns for an out-of-hospital population: a novel approach to studying the epidemiology of anaphylaxis. J Allergy Clin Immunol 110 (2002) 647-651
17. Yocum M.W., Butterfield J.H., Klein J.S., Volcheck G.W., Schroeder D.R., and Silverstein M.D. Epidemiology of anaphylaxis in Olmsted County: a population-based study. J Allergy Clin Immunol 104 (1999) 452-456
18. Lieberman P. Anaphylaxis and anaphylactoid reactions. In: Adkinson Jr. N.F., Yunginger J.W., Busse W.W., et al. (Eds). Middleton's allergy: principles and practice. 6th ed. (2003), Mosby-Year Book, St Louis 1497-1522
19. Webb L.M., and Lieberman P. Anaphylaxis: a review of 601 cases. Ann Allergy Asthma Immunol 97 (2006) 39-43
20. Kanny G., Moneret-Vautrin D.A., Flabbee J., Beaudouin E., Morisset M., and Thevenin F. Population study of food allergy in France. J Allergy Clin Immunol 108 (2001) 133-140
21. Bansal P.J., Marsh R., Patel B., and Tobin M.C. Recognition, evaluation, and treatment of anaphylaxis in the child care setting. Ann Allergy Asthma Immunol 94 (2005) 55-59
22. Mullins R.J. Anaphylaxis: risk factors for recurrence. Clin Exp Allergy 33 (2003) 1033-1040
23. Clark S., Gaeta T.J., Kamarthi G.S., and Camargo C.A. ICD-9-CM coding of emergency department visits for food and insect sting allergy. Ann Epidemiol 16 (2006) 696-700